| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-05 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.13 | 3e-05 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.12 | 6e-05 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-05 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.11 | 7e-05 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-05 |